Treatment of COPD: from pharmacological to instrumental therapies

No abstract is available for this paper.

• Publication year

  2010

• Venue

  European Respiratory Review

• Publication date

  2010-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1183/09059180.00008009PMID 20956161PMCID PMC9491646
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Increased relative mortality in women with severe oxygen-dependent COPD.

  2010cited by this paper
• Expansion of the prognostic assessment of patients with chronic obstructive pulmonary disease: the updated BODE index and the ADO index.

  2009cited by this paper
• Validation and pilot clinical study of a new bronchoscopic method to measure collateral ventilation before endobronchial lung volume reduction.

  2009cited by this paper
• Time to define the disorders of the syndrome of COPD.

  2009cited by this paper
• Pneumonia risk in COPD patients receiving inhaled corticosteroids alone or in combination: TORCH study results

  2009cited by this paper
• Inhaled corticosteroids in COPD: the case against

  2009cited by this paper
• Nocturnal non-invasive nasal ventilation in stable hypercapnic COPD: a randomised controlled trial

  2009cited by this paper
• Biologic lung volume reduction in advanced upper lobe emphysema: phase 2 results.

  2009cited by this paper
• An economic analysis of pharmacological treatment of COPD in Spain.

  2009cited by this paper
• Telemedicine for management of patients with COPD?

  2009cited by this paper
• Phosphodiesterase-4 inhibition in COPD.

  2009cited by this paper
• Defining Disease Modification in Chronic Obstructive Pulmonary Disease

  2009cited by this paper
• Daily physical activity in patients with chronic obstructive pulmonary disease is mainly associated with dynamic hyperinflation.

  2009cited by this paper
• Adherence to inhaled therapy, mortality and hospital admission in COPD

  2009cited by this paper
• Low-dose theophylline enhances the anti-inflammatory effects of steroids during exacerbations of COPD

  2009cited by this paper
• High-intensity non-invasive positive pressure ventilation for stable hypercapnic COPD

  2009cited by this paper
• Effect of tiotropium on outcomes in patients with moderate chronic obstructive pulmonary disease (UPLIFT): a prespecified subgroup analysis of a randomised controlled trial.

  2009cited by this paper
• Distinct clinical phenotypes of airways disease defined by cluster analysis

  2009cited by this paper
• Collateral damage assessment for endobronchial lung volume reduction.

  2009cited by this paper
• Study design considerations in a large COPD trial comparing effects of tiotropium with salmeterol on exacerbations

  2009cited by this paper
• Inhaled drugs to reduce exacerbations in patients with chronic obstructive pulmonary disease: a network meta-analysis

  2009cited by this paper
• Mortality in the 4-year trial of tiotropium (UPLIFT) in patients with chronic obstructive pulmonary disease.

  2009cited by this paper
• How to increase the value of randomised trials in COPD research

  2009cited by this paper
• Emerging inhaled bronchodilators: an update

  2009cited by this paper
• Theophylline again? Reasons for believing

  2009cited by this paper
• Noninvasive ventilation in pulmonary rehabilitation of COPD patients.

  2009cited by this paper
• Budesonide and the risk of pneumonia: a meta-analysis of individual patient data.

  2009cited by this paper
• Inhaled corticosteroids in COPD: a case in favour

  2009cited by this paper
• Roflumilast in moderate-to-severe chronic obstructive pulmonary disease treated with longacting bronchodilators: two randomised clinical trials.

  2009cited by this paper
• Physical activity and clinical and functional status in COPD.

  2009cited by this paper
• Is treatment with ICS and LABA cost-effective for COPD? Multinational economic analysis of the TORCH study

  2009cited by this paper
• Safety and efficacy of combined long-acting beta-agonists and inhaled corticosteroids vs long-acting beta-agonists monotherapy for stable COPD: a systematic review.

  2009cited by this paper
• Activity limitation: a major consequence of dyspnoea in COPD

  2009cited by this paper
• Efficacy and tolerability of budesonide/formoterol added to tiotropium in patients with chronic obstructive pulmonary disease.

  2009cited by this paper
• A specific home care program improves the survival of patients with chronic obstructive pulmonary disease receiving long term oxygen therapy.

  2009cited by this paper
• Cough and sputum production are associated with frequent exacerbations and hospitalizations in COPD subjects.

  2009cited by this paper
• Roflumilast in symptomatic chronic obstructive pulmonary disease: two randomised clinical trials.

  2009cited by this paper
• Methods for therapeutic trials in COPD: lessons from the TORCH trial

  2009cited by this paper
• Medication adherence issues in patients treated for COPD

  2008cited by this paper
• Inhaled corticosteroids in patients with stable chronic obstructive pulmonary disease: a systematic review and meta-analysis.

  2008cited by this paper
• One-year non-invasive ventilation in chronic hypercapnic COPD: effect on quality of life.

  2008cited by this paper
• Bronchoscopic lung volume reduction in severe emphysema.

  2008cited by this paper
• Computed tomography assessment of lung volume changes after bronchial valve treatment

  2008cited by this paper
• A 4-year trial of tiotropium in chronic obstructive pulmonary disease.

  2008cited by this paper
• SURGERY FOR BULLOUS DISEASE

  2008cited by this paper
• Pearsonʼs Thoracic and Esophageal Surgery, 3rd ed.

  2008cited by this paper
• Tiotropium in Combination with Placebo, Salmeterol, or Fluticasone-Salmeterol for Treatment of Chronic Obstructive Pulmonary Disease: A Randomized Trial

  2008cited by this paper
• Nocturnal non-invasive ventilation in addition to rehabilitation in hypercapnic patients with COPD

  2008cited by this paper
• Preserving Oxygenation during Walking in Severe Chronic Obstructive Pulmonary Disease: Noninvasive Ventilation versus Oxygen Therapy

  2008cited by this paper
• Superiority of “triple” therapy with salmeterol/fluticasone propionate and tiotropium bromide versus individual components in moderate to severe COPD

  2008cited by this paper
• The prevention of chronic obstructive pulmonary disease exacerbations by salmeterol/fluticasone propionate or tiotropium bromide.

  2008cited by this paper
• Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: results from the TORCH study.

  2008cited by this paper
• Patterns of domestic activity and ambulatory oxygen usage in COPD.

  2008cited by this paper
• Time-dependent confounding in the study of the effects of regular physical activity in chronic obstructive pulmonary disease: an application of the marginal structural model.

  2008cited by this paper
• Update on the management of COPD.

  2008cited by this paper
• Comparing supplementary oxygen benefits from a portable oxygen concentrator and a liquid oxygen portable device during a walk test in COPD patients on long-term oxygen therapy.

  2008cited by this paper
• Tele-assistance in chronic respiratory failure patients: a randomised clinical trial

  2008cited by this paper
• Inspired fraction of carbon dioxide in oxygen supply to chronic pulmonary disease.

  2008cited by this paper
• Outcomes for COPD pharmacological trials: from lung function to biomarkers

  2008cited by this paper
• Evaluation of COPD Longitudinally to Identify Predictive Surrogate End-points (ECLIPSE)

  2008cited by this paper
• Changes in arterial oxygenation and self-reported oxygen use after lung volume reduction surgery.

  2008cited by this paper
• Predictors of first-year survival in patients with advanced COPD treated using long-term oxygen therapy.

  2008cited by this paper
• Oxygen generation by combined electrolysis and fuel-cell technology: clinical use in COPD patients requiring long time oxygen therapy.

  2008cited by this paper
• Chicken or egg: physical activity in COPD revisited

  2008cited by this paper
• Therapies for COPD

  2008cited by this paper
• Airway bypass improves the mechanical properties of explanted emphysematous lungs.

  2008cited by this paper
• Cost effectiveness of therapy with combinations of long acting bronchodilators and inhaled steroids for treatment of COPD

  2008cited by this paper
• Outcomes for COPD pharmacological trials: From lung function to biomarkers.

  2008cited by this paper
• Mechanisms of improvement of respiratory failure in patients with COPD treated with NIV

  2008cited by this paper
• The effect of lung volume reduction surgery on chronic obstructive pulmonary disease exacerbations.

  2008cited by this paper
• Impact of home mechanical ventilation on health-related quality of life

  2008cited by this paper
• Ambulatory Gas Usage in Patients With Chronic Obstructive Pulmonary Disease and Exertional Hypoxemia

  2008cited by this paper
• Design of the Endobronchial Valve for Emphysema Palliation Trial (VENT): a non-surgical method of lung volume reduction

  2007cited by this paper
• CHRONIC OBSTRUCTIVE PULMONARY DISEASE Short burst oxygen therapy after activities of daily living in the home in chronic obstructive pulmonary disease

  2007cited by this paper
• Noninvasive ventilation during walking in patients with severe COPD: a randomised cross-over trial

  2007cited by this paper
• Systematic review of noninvasive positive pressure ventilation in severe stable COPD

  2007cited by this paper
• Effect of oxygen on health quality of life in patients with chronic obstructive pulmonary disease with transient exertional hypoxemia.

  2007cited by this paper
• Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary.

  2007cited by this paper
• A systematic review of randomized controlled trials examining the short-term benefit of ambulatory oxygen in COPD.

  2007cited by this paper
• A multicenter trial of an intrabronchial valve for treatment of severe emphysema.

  2007cited by this paper
• Oximetry feedback flow control simulation for oxygen therapy

  2007cited by this paper
• Effects of an integrated care intervention on risk factors of COPD readmission.

  2007cited by this paper
• Tiotropium in Combination with Placebo, Salmeterol, or FluticasoneSalmeterol for Treatment of Chronic Obstructive Pulmonary Disease

  2007cited by this paper
• Biological lung volume reduction: a new bronchoscopic therapy for advanced emphysema.

  2007cited by this paper
• Predictors of survival in COPD patients with chronic hypercapnic respiratory failure receiving noninvasive home ventilation.

  2007cited by this paper
• Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease.

  2007cited by this paper
• Bronchoscopic Lung Volume Reduction for End-Stage Emphysema: Report on the First 98 Patients

  2007cited by this paper
• Nat. Rev. Drug Disc.

  2007cited by this paper
• Transbronchoscopic pulmonary emphysema treatment: 1-month to 24-month endoscopic follow-up.

  2006cited by this paper
• Long-term oxygen treatment in chronic obstructive pulmonary disease: recommendations for future research: an NHLBI workshop report.

  2006cited by this paper
• Integrated care: a new model for COPD management?

  2006cited by this paper
• Bronchoscopic lung volume reduction for end-stage emphysema: report on the first 98 patients.

  2006cited by this paper
• Surgical Options for Patients With COPD: Sorting Out the Choices

  2006cited by this paper
• BMC Pulmonary Medicine BioMed Central Study protocol

  2006cited by this paper
• Effect of fluticasone propionate/salmeterol on lung hyperinflation and exercise endurance in COPD.

  2006cited by this paper
• Airway epithelial repair, regeneration, and remodeling after injury in chronic obstructive pulmonary disease.

  2006cited by this paper
• The effect of tiotropium on exacerbations and airflow in patients with COPD.

  2006cited by this paper
• Elective surgery for giant bullous emphysema: a 5-year clinical and functional follow-up.

  2005cited by this paper
• Bronchoscopic lung-volume reduction with one-way valves in patients with heterogenous emphysema.

  2005cited by this paper
• Outcome of patients with stable COPD receiving controlled noninvasive positive pressure ventilation aimed at a maximal reduction of Pa(CO2).

  2005cited by this paper

• A study to evaluate the knowledge, attitude, and practice for the use of inhalational devices among asthma patients and copd patients in a tertiary-care teaching hospital, a cross-sectional study

  2024cites this paper
• Exploring Inflammatory Dysregulation in Alveolar Macrophages: Implications for Novel Therapeutic Targets in Chronic Obstructive Pulmonary Disease

  2024cites this paper
• Airway dysbiosis accelerates lung function decline in chronic obstructive pulmonary disease.

  2023cites this paper
• Compliance of Pharmacotherapy with GOLD Guidelines: A Longitudinal Study in Patients with COPD

  2020cites this paper
• Compliance of Pharmacotherapy with GOLD Guidelines: A Longitudinal Study in Patients with COPD

  2020cites this paper
• Knowledge and practice of dry powder inhalation among patients with chronic obstructive pulmonary disease in a regional hospital, Nepal

  2018cites this paper
• Atorvastatin and Simvastatin Promoted Mouse Lung Repair After Cigarette Smoke-Induced Emphysema

  2017cites this paper
• Capsazepine, rimonabant, WIN55, 212-2 and lidocaine attenuated acute lung inflammation induced by co-exposure of capsaicin and cigarette smoke extract in rats

  2015cites this paper
• Optimizing perioperative care for patients with hip fracture.

  2014cites this paper
• Phase III Clinical Efficacy of Indacaterol: Patient-Centered Outcomes

  2014cites this paper
• TNF-α-induced CXCL8 production by A549 cells: involvement of the non-neuronal cholinergic system.

  2013cites this paper
• COPD: Overview and survey of NP knowledge

  2013cites this paper
• COPD in primary care settings in Ireland: stories from usual care.

  2013cites this paper
• Oxygénothérapie à long terme dans la broncho- pulmonaire chronique obstructive (BPCO) Long-term oxygenotherapy in chronic obstructive pulmonary disease (COPD)

  2013influential citation
• Roflumilast Inhibits Lipopolysaccharide-Induced Tumor Necrosis Factor-α and Chemokine Production by Human Lung Parenchyma

  2013cites this paper
• The development and application of an antibody microarray as a diagnostic platform for COPD

  2013cites this paper
• You say goodbye, and I say hello!

  2012cites this paper
• Overview of muscarinic receptor subtypes.

  2012cites this paper
• Suppressed Expression of T-Box Transcription Factors Is Involved in Senescence in Chronic Obstructive Pulmonary Disease

  2012cites this paper
• Inflammation in COPD and New Drug Strategies

  2012cites this paper
• Update on the roles of distal airways in COPD

  2011cites this paper
• Applicability and generalizability of palliative interventions for dyspnoea: one size fits all, some or none?

  2011cites this paper
• Title Pre-operative pulmonary assessment for patients with hipfracture

  2010cites this paper
• Update on the European Respiratory Review

  2010cites this paper
• Pre-operative pulmonary assessment for patients with hip fracture

  2010cites this paper
• Genome-wide copy number variation association study suggested VPS13B gene for osteoporosis in Caucasians

  2010cites this paper